OneSource Specialty Pharma will host a physical group investor meeting on September 3, 2026. The event aims to engage analysts and investors on the company's business overview and strategic outlook.

The interaction is scheduled to take place at the company's manufacturing facility in Doddaballapura, Bengaluru Rural District. Representatives from OneSource will discuss publicly available information, including industry trends and growth prospects.

Meeting Details

The company disclosed the schedule pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is open to analysts and institutional investors.

Compliance and Disclosure

The company confirmed that no unpublished price-sensitive information (UPSI) will be shared during the session. All discussions will remain within the scope of publicly available data. A. Trisha, Company Secretary and Compliance Officer, signed the intimation letter dated August 31, 2026.

OneSource Specialty Pharma Limited has scheduled its 19th Annual General Meeting for September 23, 2026. The meeting will be conducted through Video Conferencing or Other Audio Visual Means.

Meeting Details

The company will hold the meeting at 11:00 am IST. The session is designated as the second AGM post-listing. It aims to transact business set forth in the notice convening the meeting.

Shareholder Participation

Shareholders can join and participate in the AGM only through the VC/OAVM facility. The company will send the notice and annual report for the financial year 2025-26 electronically to members with registered email addresses. These documents are also available on the company website and stock exchange portals.

The company provides a remote e-voting facility for all resolutions. Members who do not vote remotely can exercise their voting rights during the AGM via the e-voting system. Mr. Pradeep Bheemsen Kulkarni of M/s. V Sreedharan & Associates has been appointed as the scrutinizer for the voting process.